id,created_at,text,favorites,retweets,entities,language
1351982107355213824,2021-01-20 19:57:07,Our researchers found that the sera of BNT162 trial participants inhibited pseudovirus bearing the UK strain SARS-C‚Ä¶ https://t.co/mwqnqSjGye,222,60,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/mwqnqSjGye', 'expanded_url': 'https://twitter.com/i/web/status/1351982107355213824', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1349419157679468549,2021-01-13 18:12:52,RT @TheReisGroup: @MatthewHerper asked about the reaction upon learning their #COVIDvaccine was 95% effective: ‚ÄúIt was a very emotional mom‚Ä¶,0,6,"{'hashtags': [{'text': 'COVIDvaccine', 'indices': [78, 91]}], 'symbols': [], 'user_mentions': [{'screen_name': 'TheReisGroup', 'name': 'The Reis Group', 'id': 722493987400073218, 'id_str': '722493987400073218', 'indices': [3, 16]}, {'screen_name': 'matthewherper', 'name': 'Matthew Herper', 'id': 44438256, 'id_str': '44438256', 'indices': [18, 32]}], 'urls': []}",en
1348715973868720130,2021-01-11 19:38:40,We are honored that our co-founders Dr. Ugur Sahin and Dr. √ñzlem T√ºreci are featured on the cover of @TIME this wee‚Ä¶ https://t.co/2gDEWH8lOv,1285,194,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'TIME', 'name': 'TIME', 'id': 14293310, 'id_str': '14293310', 'indices': [101, 106]}], 'urls': [{'url': 'https://t.co/2gDEWH8lOv', 'expanded_url': 'https://twitter.com/i/web/status/1348715973868720130', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1342936103024779271,2020-12-26 20:51:32,All 27 EU Member States received their first batches of our #COVID19 vaccine. The picture below shows a couple of t‚Ä¶ https://t.co/ZUzQMQLo96,865,19,"{'hashtags': [{'text': 'COVID19', 'indices': [60, 68]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/ZUzQMQLo96', 'expanded_url': 'https://twitter.com/i/web/status/1342936103024779271', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1341103794894073858,2020-12-21 19:30:35,The @EU_Commission granted Conditional Marketing Authorization for our #mRNA #COVID19 for all 27 member states. For‚Ä¶ https://t.co/wGDd6IiGw4,495,9,"{'hashtags': [{'text': 'mRNA', 'indices': [71, 76]}, {'text': 'COVID19', 'indices': [77, 85]}], 'symbols': [], 'user_mentions': [{'screen_name': 'EU_Commission', 'name': 'European Commission üá™üá∫', 'id': 157981564, 'id_str': '157981564', 'indices': [4, 18]}], 'urls': [{'url': 'https://t.co/wGDd6IiGw4', 'expanded_url': 'https://twitter.com/i/web/status/1341103794894073858', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1338843942075428868,2020-12-15 13:50:44,"RT @vonderleyen: Every day counts - we work at full speed to authorise #COVID19 vaccines that are safe &amp; effective.
¬†
I welcome @EMA_News b‚Ä¶",0,399,"{'hashtags': [{'text': 'COVID19', 'indices': [71, 79]}], 'symbols': [], 'user_mentions': [{'screen_name': 'vonderleyen', 'name': 'Ursula von der Leyen', 'id': 1146329871418843136, 'id_str': '1146329871418843136', 'indices': [3, 15]}, {'screen_name': 'EMA_News', 'name': 'EU Medicines Agency', 'id': 116716199, 'id_str': '116716199', 'indices': [132, 141]}], 'urls': []}",en
1337628754844246017,2020-12-12 05:22:01,Our #vaccine candidate #BNT162b2 has been authorized by the @US_FDA for emergency use in the U.S. We stand ready to‚Ä¶ https://t.co/n0MUqFLYqQ,742,120,"{'hashtags': [{'text': 'vaccine', 'indices': [4, 12]}, {'text': 'BNT162b2', 'indices': [23, 32]}], 'symbols': [], 'user_mentions': [{'screen_name': 'US_FDA', 'name': 'U.S. FDA', 'id': 208120290, 'id_str': '208120290', 'indices': [60, 67]}], 'urls': [{'url': 'https://t.co/n0MUqFLYqQ', 'expanded_url': 'https://twitter.com/i/web/status/1337628754844246017', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1336371803539857408,2020-12-08 18:07:21,"How do #mRNA vaccines work? The @nytimes offers an overview of the mode of action
https://t.co/zpyWq4454B",328,119,"{'hashtags': [{'text': 'mRNA', 'indices': [7, 12]}], 'symbols': [], 'user_mentions': [{'screen_name': 'nytimes', 'name': 'The New York Times', 'id': 807095, 'id_str': '807095', 'indices': [32, 40]}], 'urls': [{'url': 'https://t.co/zpyWq4454B', 'expanded_url': 'https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html', 'display_url': 'nytimes.com/interactive/20‚Ä¶', 'indices': [82, 105]}]}",en
1334539617022996481,2020-12-03 16:46:53,"RT @bopanc: The married couple Ugur Sahin and √ñzlem T√ºreci, founders of ‚Å¶@BioNTech_Group, invented the‚Å© first #COVID19 vaccine to be author‚Ä¶",0,449,"{'hashtags': [{'text': 'COVID19', 'indices': [110, 118]}], 'symbols': [], 'user_mentions': [{'screen_name': 'bopanc', 'name': 'Bojan Pancevski', 'id': 207441433, 'id_str': '207441433', 'indices': [3, 10]}, {'screen_name': 'BioNTech_Group', 'name': 'BioNTech SE', 'id': 1060984350995550208, 'id_str': '1060984350995550208', 'indices': [73, 88]}], 'urls': []}",en
1334032545768484864,2020-12-02 07:11:58,"Exciting news: We received the world‚Äôs first authorization of a #COVID19 #vaccine, with @MHRA granting emergency us‚Ä¶ https://t.co/1aDn0JxIGH",1145,324,"{'hashtags': [{'text': 'COVID19', 'indices': [64, 72]}, {'text': 'vaccine', 'indices': [73, 81]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/1aDn0JxIGH', 'expanded_url': 'https://twitter.com/i/web/status/1334032545768484864', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1333723029562646528,2020-12-01 10:42:04,We have submitted a formal Application for Conditional Marketing Authorization to @EMA_News for #mRNA vaccine candi‚Ä¶ https://t.co/TNAOKw951g,631,124,"{'hashtags': [{'text': 'mRNA', 'indices': [96, 101]}], 'symbols': [], 'user_mentions': [{'screen_name': 'EMA_News', 'name': 'EU Medicines Agency', 'id': 116716199, 'id_str': '116716199', 'indices': [82, 91]}], 'urls': [{'url': 'https://t.co/TNAOKw951g', 'expanded_url': 'https://twitter.com/i/web/status/1333723029562646528', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1331629290786611201,2020-11-25 16:02:18,We‚Äôre excited to announce a new¬†strategic collaboration: We'll be establishing an #AI Innovation #Lab with‚Ä¶ https://t.co/KPomgzTNLQ,164,39,"{'hashtags': [{'text': 'AI', 'indices': [82, 85]}, {'text': 'Lab', 'indices': [97, 101]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/KPomgzTNLQ', 'expanded_url': 'https://twitter.com/i/web/status/1331629290786611201', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [108, 131]}]}",en
1329754864851841025,2020-11-20 11:54:00,We are submitting our first request for an #EUA in the U.S. for vaccine candidate #BNT162b2 against #covid19. We lo‚Ä¶ https://t.co/ZhnibXCZHs,852,184,"{'hashtags': [{'text': 'EUA', 'indices': [43, 47]}, {'text': 'BNT162b2', 'indices': [82, 91]}, {'text': 'covid19', 'indices': [100, 108]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/ZhnibXCZHs', 'expanded_url': 'https://twitter.com/i/web/status/1329754864851841025', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1329102103495778304,2020-11-18 16:40:09,"We have reached the final #efficacy analysis mark, indicating a high rate of protection against #COVID19 can be ach‚Ä¶ https://t.co/tiEw6wsFS0",638,171,"{'hashtags': [{'text': 'efficacy', 'indices': [26, 35]}, {'text': 'COVID19', 'indices': [96, 104]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/tiEw6wsFS0', 'expanded_url': 'https://twitter.com/i/web/status/1329102103495778304', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1329067110727774209,2020-11-18 14:21:06,"RT @megtirrell: Pfizer &amp; BioNTech final results on #covid19 vaccine phase 3: *95% effective*

170 cases in trial
-162 among placebo group
-‚Ä¶",0,278,"{'hashtags': [{'text': 'covid19', 'indices': [55, 63]}], 'symbols': [], 'user_mentions': [{'screen_name': 'megtirrell', 'name': 'Meg Tirrell', 'id': 47678782, 'id_str': '47678782', 'indices': [3, 14]}], 'urls': []}",en
1328324340958564353,2020-11-16 13:09:36,To our #Twitter community: Please note there are no personal accounts being run by our executives. We are already i‚Ä¶ https://t.co/IPr0VVwOz1,393,106,"{'hashtags': [{'text': 'Twitter', 'indices': [7, 15]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/IPr0VVwOz1', 'expanded_url': 'https://twitter.com/i/web/status/1328324340958564353', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1325153359163224064,2020-11-07 19:09:15,‰Ω†Â•ΩN«ê h«éo from China! This week we participated in @ciieonline to showcase our #mRNA technology and how we aim to le‚Ä¶ https://t.co/Ku2FTcU5Kg,324,62,"{'hashtags': [{'text': 'mRNA', 'indices': [78, 83]}], 'symbols': [], 'user_mentions': [{'screen_name': 'ciieonline', 'name': 'China International Import Expo', 'id': 974548718446821381, 'id_str': '974548718446821381', 'indices': [50, 61]}], 'urls': [{'url': 'https://t.co/Ku2FTcU5Kg', 'expanded_url': 'https://twitter.com/i/web/status/1325153359163224064', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1323946482790182913,2020-11-04 11:13:33,RT @FTLiveHealth: Don‚Äôt miss a panel discussion on coronavirus as a 21st century case study on pharma and health with Richard Hatchett @CEP‚Ä¶,0,19,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'FTLiveHealth', 'name': 'FT Live Health', 'id': 3513690934, 'id_str': '3513690934', 'indices': [3, 16]}], 'urls': []}",en
1323218498336788480,2020-11-02 11:00:48,We are excited to welcome the latest addition to the BioNTech family: our colleagues in Marburg. The tech transfer‚Ä¶ https://t.co/E2BFuOj7jI,339,56,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/E2BFuOj7jI', 'expanded_url': 'https://twitter.com/i/web/status/1323218498336788480', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1319226391561490432,2020-10-22 10:37:36,RT @bopanc: How a Little-known German Biotech Firm Founded by the Children of Turkish Immigrants Became a Leader in Global #Coronavirus Vac‚Ä¶,0,373,"{'hashtags': [{'text': 'Coronavirus', 'indices': [123, 135]}], 'symbols': [], 'user_mentions': [{'screen_name': 'bopanc', 'name': 'Bojan Pancevski', 'id': 207441433, 'id_str': '207441433', 'indices': [3, 10]}], 'urls': []}",en
1317099411768565761,2020-10-16 13:45:44,We provided an update on the potential timelines for the #COVID19 #vaccine candidate BNT162b2. We will seek approva‚Ä¶ https://t.co/ddEuABylAg,295,95,"{'hashtags': [{'text': 'COVID19', 'indices': [57, 65]}, {'text': 'vaccine', 'indices': [66, 74]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/ddEuABylAg', 'expanded_url': 'https://twitter.com/i/web/status/1317099411768565761', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1316644919130435584,2020-10-15 07:39:45,"RT @Genmab: We‚Äôre excited to share updates from Genmab‚Äôs pipeline at the virtual #SITC2020, including first-in-human data on a bispecific #‚Ä¶",0,11,"{'hashtags': [{'text': 'SITC2020', 'indices': [81, 90]}], 'symbols': [], 'user_mentions': [{'screen_name': 'Genmab', 'name': 'Genmab', 'id': 4353611175, 'id_str': '4353611175', 'indices': [3, 10]}], 'urls': []}",en
1316644469966622724,2020-10-15 07:37:58,Phase 1 data of our #COVID19 #vaccine candidate BNT162b2 was published in the @NEJM. It shows that BNT162b2 induces‚Ä¶ https://t.co/85O8KmVzTm,193,49,"{'hashtags': [{'text': 'COVID19', 'indices': [20, 28]}, {'text': 'vaccine', 'indices': [29, 37]}], 'symbols': [], 'user_mentions': [{'screen_name': 'NEJM', 'name': 'NEJM', 'id': 25950355, 'id_str': '25950355', 'indices': [78, 83]}], 'urls': [{'url': 'https://t.co/85O8KmVzTm', 'expanded_url': 'https://twitter.com/i/web/status/1316644469966622724', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1314570122581999617,2020-10-09 14:15:15,"On Oct 10 2019, we joined @Nasdaq as $BNTX. Since then, we not only established our US headquarters, raised more th‚Ä¶ https://t.co/mhLaMkHYp0",164,28,"{'hashtags': [], 'symbols': [{'text': 'BNTX', 'indices': [37, 42]}], 'user_mentions': [{'screen_name': 'Nasdaq', 'name': 'Nasdaq', 'id': 18639734, 'id_str': '18639734', 'indices': [26, 33]}], 'urls': [{'url': 'https://t.co/mhLaMkHYp0', 'expanded_url': 'https://twitter.com/i/web/status/1314570122581999617', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1313425654667456513,2020-10-06 10:27:32,We initiated a rolling submission to @EMA_News for our #COVID19 #vaccine candidate BNT162b2. #CHMP will now start r‚Ä¶ https://t.co/p3gJhoTGk1,174,45,"{'hashtags': [{'text': 'COVID19', 'indices': [55, 63]}, {'text': 'vaccine', 'indices': [64, 72]}, {'text': 'CHMP', 'indices': [93, 98]}], 'symbols': [], 'user_mentions': [{'screen_name': 'EMA_News', 'name': 'EU Medicines Agency', 'id': 116716199, 'id_str': '116716199', 'indices': [37, 46]}], 'urls': [{'url': 'https://t.co/p3gJhoTGk1', 'expanded_url': 'https://twitter.com/i/web/status/1313425654667456513', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1311554342818906112,2020-10-01 06:31:37,RT @EuropaBio: Starting soon - How can we prepare for future pandemics? Join us for our next @biotechweek event now w/ @EPPGroup's @peterli‚Ä¶,0,6,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'EuropaBio', 'name': 'EuropaBio', 'id': 19642657, 'id_str': '19642657', 'indices': [3, 13]}, {'screen_name': 'biotechweek', 'name': 'biotechweek', 'id': 745020536, 'id_str': '745020536', 'indices': [93, 105]}, {'screen_name': 'EPPGroup', 'name': 'EPP Group', 'id': 53347647, 'id_str': '53347647', 'indices': [119, 128]}], 'urls': []}",en
1306560951634800640,2020-09-17 11:49:40,"Today we announced the acquisition of a manufacturing facility in Marburg, Germany. The site, which should be fully‚Ä¶ https://t.co/BXINCTqSrm",251,59,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/BXINCTqSrm', 'expanded_url': 'https://twitter.com/i/web/status/1306560951634800640', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1306115992314093568,2020-09-16 06:21:33,We are delighted to welcome 14 new apprentices at @BioNTech who share our vision to individualize cancer medicine.‚Ä¶ https://t.co/qTxNdDyvaT,61,7,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'biontech', 'name': 'chinedu nzelu', 'id': 45145924, 'id_str': '45145924', 'indices': [50, 59]}], 'urls': [{'url': 'https://t.co/qTxNdDyvaT', 'expanded_url': 'https://twitter.com/i/web/status/1306115992314093568', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1305841016281477120,2020-09-15 12:08:54,We are excited to receive a grant of up to ‚Ç¨375M from the German Federal Ministry of Education and Research to acce‚Ä¶ https://t.co/LgncbJsSb7,127,28,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/LgncbJsSb7', 'expanded_url': 'https://twitter.com/i/web/status/1305841016281477120', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1304073628900823040,2020-09-10 15:05:56,"RT @pfizer_de: ""Innovationen kommen aus Unternehmen, Universit√§ten und Kooperationen mit Organisationen und Regierungen. Kooperationen habe‚Ä¶",0,6,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'pfizer_de', 'name': 'Pfizer Deutschland', 'id': 207421760, 'id_str': '207421760', 'indices': [3, 13]}], 'urls': []}",de
1303644149317603328,2020-09-09 10:39:20,We announced that we have concluded exploratory talks with the @EU_Commission for a proposed supply of 200 million‚Ä¶ https://t.co/cBoKPfPIrI,163,44,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'EU_Commission', 'name': 'European Commission üá™üá∫', 'id': 157981564, 'id_str': '157981564', 'indices': [63, 77]}], 'urls': [{'url': 'https://t.co/cBoKPfPIrI', 'expanded_url': 'https://twitter.com/i/web/status/1303644149317603328', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1303323757713543169,2020-09-08 13:26:13,"Today and every day, we put #science first. We are committed to the safety &amp; efficacy of #vaccines &amp; testing potent‚Ä¶ https://t.co/x4gL5AZhvP",133,24,"{'hashtags': [{'text': 'science', 'indices': [28, 36]}, {'text': 'vaccines', 'indices': [93, 102]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/x4gL5AZhvP', 'expanded_url': 'https://twitter.com/i/web/status/1303323757713543169', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [125, 148]}]}",en
1296789449465114624,2020-08-21 12:41:12,We just shared new key data from our U.S. Phase 1 trial for our lead vaccine candidate against #COVID19#BNT162b2. O‚Ä¶ https://t.co/m1KMCfeRNq,177,46,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/m1KMCfeRNq', 'expanded_url': 'https://twitter.com/i/web/status/1296789449465114624', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1293177885889626113,2020-08-11 13:30:08,"Today, we provided an update on our corporate progress and reported financial results for Q2. We made significant p‚Ä¶ https://t.co/ael31umiYS",72,13,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/ael31umiYS', 'expanded_url': 'https://twitter.com/i/web/status/1293177885889626113', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1290988129235730433,2020-08-05 12:28:50,‚ÄúWe are proud to be among the first international biopharmaceutical companies to initiate a clinical trial of a‚Ä¶ https://t.co/ACWunqyRK4,120,27,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/ACWunqyRK4', 'expanded_url': 'https://twitter.com/i/web/status/1290988129235730433', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [113, 136]}]}",en
1289194872449175552,2020-07-31 13:43:04,We announced an agreement with #Japan for 120m doses of our mRNA-based vaccine candidate. This is part of our commi‚Ä¶ https://t.co/G6Ewcj00qw,161,39,"{'hashtags': [{'text': 'Japan', 'indices': [31, 37]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/G6Ewcj00qw', 'expanded_url': 'https://twitter.com/i/web/status/1289194872449175552', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1288197980537880580,2020-07-28 19:41:46,We announced the start of a global Phase 2/3 safety and efficacy study to evaluate a single nucleoside-modified mes‚Ä¶ https://t.co/UaKREpn7Es,149,45,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/UaKREpn7Es', 'expanded_url': 'https://twitter.com/i/web/status/1288197980537880580', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1285089344915734528,2020-07-20 05:49:10,We announced an agreement with the #UK for 30m doses of our mRNA-based vaccine candidate against #COVID19. We curre‚Ä¶ https://t.co/2eVh2rDVVu,197,60,"{'hashtags': [{'text': 'UK', 'indices': [35, 38]}, {'text': 'COVID19', 'indices': [97, 105]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/2eVh2rDVVu', 'expanded_url': 'https://twitter.com/i/web/status/1285089344915734528', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1282629076541485056,2020-07-13 10:52:56,We are proud to have received Fast Track designation from the U.S. FDA for two of our four investigational vaccine‚Ä¶ https://t.co/UdXd9FNl1Q,237,87,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/UdXd9FNl1Q', 'expanded_url': 'https://twitter.com/i/web/status/1282629076541485056', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1278405584786776065,2020-07-01 19:10:17,"Today, we announced early positive data from the #US and as part of our global #COVID19 development program in coll‚Ä¶ https://t.co/VqyopWWYh6",196,88,"{'hashtags': [{'text': 'US', 'indices': [49, 52]}, {'text': 'COVID19', 'indices': [79, 87]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/VqyopWWYh6', 'expanded_url': 'https://twitter.com/i/web/status/1278405584786776065', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1272570508979167232,2020-06-15 16:43:47,Wie gestaltet sich die Entwicklung nach einem #Impfstoff gegen #Covid19 in einem globalen Umfeld? BioNTechs Mitgr√ºn‚Ä¶ https://t.co/LauPczohlz,118,20,"{'hashtags': [{'text': 'Impfstoff', 'indices': [46, 56]}, {'text': 'Covid19', 'indices': [63, 71]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/LauPczohlz', 'expanded_url': 'https://twitter.com/i/web/status/1272570508979167232', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",de
1268887169080463365,2020-06-05 12:47:30,"RT @DIEZEIT: ""Lichtgeschwindigkeit"" haben sie ihr Projekt getauft: Die Welt vom Virus befreien. @ingomalcher hat f√ºr die neue ZEIT-Serie ""D‚Ä¶",0,17,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'DIEZEIT', 'name': 'DIE ZEIT', 'id': 1081459807, 'id_str': '1081459807', 'indices': [3, 11]}, {'screen_name': 'ingomalcher', 'name': 'Ingo Malcher', 'id': 863363072, 'id_str': '863363072', 'indices': [96, 108]}], 'urls': []}",de
1260182681607909384,2020-05-12 12:18:59,"We have made significant progress to date in 2020: We advanced our #oncology pipeline, closed the acquisition of Ne‚Ä¶ https://t.co/TRIoFcW4Um",90,17,"{'hashtags': [{'text': 'oncology', 'indices': [67, 76]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/TRIoFcW4Um', 'expanded_url': 'https://twitter.com/i/web/status/1260182681607909384', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1258140522675404808,2020-05-06 21:04:10,#BNTX grows globally: welcome to our new team members in the #US! We announced today the closing of @neon_tx. Based‚Ä¶ https://t.co/OHdvjSh9Ym,56,12,"{'hashtags': [{'text': 'BNTX', 'indices': [0, 5]}, {'text': 'US', 'indices': [61, 64]}], 'symbols': [], 'user_mentions': [{'screen_name': 'neon_tx', 'name': 'Neon Therapeutics', 'id': 1045648026793103362, 'id_str': '1045648026793103362', 'indices': [100, 108]}], 'urls': [{'url': 'https://t.co/OHdvjSh9Ym', 'expanded_url': 'https://twitter.com/i/web/status/1258140522675404808', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1258030646787801088,2020-05-06 13:47:33,Listen in to @CNN's @fpleitgenCNN discussing the progress of our global #COVID19 development program with our CEO U‚Ä¶ https://t.co/TFTM5vJ4c7,61,19,"{'hashtags': [{'text': 'COVID19', 'indices': [72, 80]}], 'symbols': [], 'user_mentions': [{'screen_name': 'CNN', 'name': 'CNN', 'id': 759251, 'id_str': '759251', 'indices': [13, 17]}, {'screen_name': 'fpleitgenCNN', 'name': 'Frederik Pleitgen', 'id': 23572083, 'id_str': '23572083', 'indices': [20, 33]}], 'urls': [{'url': 'https://t.co/TFTM5vJ4c7', 'expanded_url': 'https://twitter.com/i/web/status/1258030646787801088', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1257623354951024641,2020-05-05 10:49:07,"The first participants in the #US were dosed with #BNT162. With ongoing trials in #Europe and Northern America, our‚Ä¶ https://t.co/mxrTUBm9jw",255,86,"{'hashtags': [{'text': 'US', 'indices': [30, 33]}, {'text': 'BNT162', 'indices': [50, 57]}, {'text': 'Europe', 'indices': [82, 89]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/mxrTUBm9jw', 'expanded_url': 'https://twitter.com/i/web/status/1257623354951024641', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1255415875525586944,2020-04-29 08:37:23,"What a special moment! The first participant was dosed with our #COVID-19 vaccine candidate BNT162. Furthermore, th‚Ä¶ https://t.co/zp9iD30vLH",451,181,"{'hashtags': [{'text': 'COVID', 'indices': [64, 70]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/zp9iD30vLH', 'expanded_url': 'https://twitter.com/i/web/status/1255415875525586944', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1254807395043328004,2020-04-27 16:19:30,Wann hat unser CEO und Mitgr√ºnder Ugur Sahin intern das #Covid-19 Impfstoffprogamm initiiert? Was genau hat ihn daz‚Ä¶ https://t.co/WQQro9m1eS,82,18,"{'hashtags': [{'text': 'Covid', 'indices': [56, 62]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/WQQro9m1eS', 'expanded_url': 'https://twitter.com/i/web/status/1254807395043328004', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",de
1253375913246539793,2020-04-23 17:31:18,RT @FAZ_Top: .@BioNTech_Group hat einen ersten Durchbruch bei der Entwicklung eines Impfstoffs gegen das #Coronavirus erzielt. Hinter den g‚Ä¶,0,17,"{'hashtags': [{'text': 'Coronavirus', 'indices': [105, 117]}], 'symbols': [], 'user_mentions': [{'screen_name': 'FAZ_Top', 'name': 'FAZ Topthemen', 'id': 2962175596, 'id_str': '2962175596', 'indices': [3, 11]}, {'screen_name': 'BioNTech_Group', 'name': 'BioNTech SE', 'id': 1060984350995550208, 'id_str': '1060984350995550208', 'indices': [14, 29]}], 'urls': []}",de
1252904837165039616,2020-04-22 10:19:25,"Today, the German regulatory authority, the @PEI_Germany, approved the Phase 1/2 clinical trial for our #vaccine pr‚Ä¶ https://t.co/VUaUTkzg5u",416,193,"{'hashtags': [{'text': 'vaccine', 'indices': [104, 112]}], 'symbols': [], 'user_mentions': [{'screen_name': 'PEI_Germany', 'name': 'Paul-Ehrlich-Institut', 'id': 2396380621, 'id_str': '2396380621', 'indices': [44, 56]}], 'urls': [{'url': 'https://t.co/VUaUTkzg5u', 'expanded_url': 'https://twitter.com/i/web/status/1252904837165039616', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1248295203036966915,2020-04-09 17:02:23,We are excited to have announced additional details on our collaboration with @pfizer to rapidly advance multiple m‚Ä¶ https://t.co/zJtijHxXKf,139,57,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'pfizer', 'name': 'Pfizer Inc.', 'id': 56488059, 'id_str': '56488059', 'indices': [78, 85]}], 'urls': [{'url': 'https://t.co/zJtijHxXKf', 'expanded_url': 'https://twitter.com/i/web/status/1248295203036966915', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1245017751032336385,2020-03-31 15:58:57,"Today, we announced our full year 2019 financial results. Last year has been transformational for us. In 2020, we p‚Ä¶ https://t.co/83ViVLqfIY",54,10,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/83ViVLqfIY', 'expanded_url': 'https://twitter.com/i/web/status/1245017751032336385', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1244514032415096832,2020-03-30 06:37:21,It's important to ensure our patients in clinical trials continue to get treatment &amp; to pursue the development of a‚Ä¶ https://t.co/bampzkqDpW,89,10,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/bampzkqDpW', 'expanded_url': 'https://twitter.com/i/web/status/1244514032415096832', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",en
1241996779199123457,2020-03-23 07:54:42,"If you ever wondered what it is like to work with Ugur Sahin on the development of a #COVID„Éº19 vaccine, the @FT pro‚Ä¶ https://t.co/cVydfv4an1",94,33,"{'hashtags': [{'text': 'COVID„Éº19', 'indices': [85, 94]}], 'symbols': [], 'user_mentions': [{'screen_name': 'FT', 'name': 'Financial Times', 'id': 18949452, 'id_str': '18949452', 'indices': [108, 111]}], 'urls': [{'url': 'https://t.co/cVydfv4an1', 'expanded_url': 'https://twitter.com/i/web/status/1241996779199123457', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1240626806551650306,2020-03-19 13:10:55,"RT @BIDeutschland: Nach @CureVacAG hat nun auch die Mainzer Firma 
@BioNTech_Group angek√ºndigt, einen Impfstoff gegen das #coronavirus entw‚Ä¶",0,13,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'BIDeutschland', 'name': 'Business Insider üá©üá™', 'id': 3344215161, 'id_str': '3344215161', 'indices': [3, 17]}], 'urls': []}",de
1239950973424087048,2020-03-17 16:25:23,Watch our¬†Chief Business and Chief Commercial Office¬†Sean Marett discuss BioNTech‚Äôs vaccine program for the prevent‚Ä¶ https://t.co/a96vwZxoDN,40,16,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/a96vwZxoDN', 'expanded_url': 'https://twitter.com/i/web/status/1239950973424087048', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1239819289298903040,2020-03-17 07:42:07,"Today, we announced that we have agreed to a letter of intent regarding the co-development &amp; distribution (excl. Ch‚Ä¶ https://t.co/I7HzN7w0R6",125,65,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/I7HzN7w0R6', 'expanded_url': 'https://twitter.com/i/web/status/1239819289298903040', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",en
1239635531669164033,2020-03-16 19:31:56,RT @FAZ_Wirtschaft: Das Biotechunternehmen @BioNTech_Group kooperiert f√ºr eine Impfung jetzt mit dem #Fosun-Konzern aus China. Bald sollen‚Ä¶,0,20,"{'hashtags': [{'text': 'Fosun', 'indices': [101, 107]}], 'symbols': [], 'user_mentions': [{'screen_name': 'FAZ_Wirtschaft', 'name': 'FAZ Wirtschaft', 'id': 24870448, 'id_str': '24870448', 'indices': [3, 18]}, {'screen_name': 'BioNTech_Group', 'name': 'BioNTech SE', 'id': 1060984350995550208, 'id_str': '1060984350995550208', 'indices': [43, 58]}], 'urls': []}",de
1239454618142334976,2020-03-16 07:33:03,We are developing a potential mRNA-based vaccine to induce immunity and prevent #COVID19 infections. We initiated o‚Ä¶ https://t.co/or3UM4CkU8,166,75,"{'hashtags': [{'text': 'COVID19', 'indices': [80, 88]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/or3UM4CkU8', 'expanded_url': 'https://twitter.com/i/web/status/1239454618142334976', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1236588902733041665,2020-03-08 09:45:43,"Today, we especially celebrate our female co-workers striving to turn our vision of individualized #cancer medicine‚Ä¶ https://t.co/5S6PKKedxl",21,5,"{'hashtags': [{'text': 'cancer', 'indices': [99, 106]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/5S6PKKedxl', 'expanded_url': 'https://twitter.com/i/web/status/1236588902733041665', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1233381606171303936,2020-02-28 13:21:04,"At @SVBLeerink‚Äôs Global Healthcare Conference, Sean Marett and Ryan Richardson discussed our vertically integrated‚Ä¶ https://t.co/58fmovq8Vl",10,1,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'SVBLeerink', 'name': 'SVB Leerink', 'id': 70731075, 'id_str': '70731075', 'indices': [3, 14]}], 'urls': [{'url': 'https://t.co/58fmovq8Vl', 'expanded_url': 'https://twitter.com/i/web/status/1233381606171303936', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1233023591865868290,2020-02-27 13:38:27,2019 haben wir $225m mit einer Series B-Finanzierungsrunde &amp; $149m mit einem @Nasdaq #IPO akquiriert. Laut @FAZ geh‚Ä¶ https://t.co/m7hlsDO05Q,19,5,"{'hashtags': [{'text': 'IPO', 'indices': [89, 93]}], 'symbols': [], 'user_mentions': [{'screen_name': 'Nasdaq', 'name': 'Nasdaq', 'id': 18639734, 'id_str': '18639734', 'indices': [81, 88]}, {'screen_name': 'faz', 'name': 'Faz Besharatian', 'id': 7174, 'id_str': '7174', 'indices': [111, 115]}], 'urls': [{'url': 'https://t.co/m7hlsDO05Q', 'expanded_url': 'https://twitter.com/i/web/status/1233023591865868290', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",de
1228316610626232320,2020-02-14 13:54:35,"By combining groundbreaking research with cutting-edge technologies, we are building a 21st century company in orde‚Ä¶ https://t.co/WJXE68MHgH",25,7,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/WJXE68MHgH', 'expanded_url': 'https://twitter.com/i/web/status/1228316610626232320', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1217896385523191808,2020-01-16 19:48:20,We are excited to announce that we have entered into a definitive #merger #agreement under which we will acquire‚Ä¶ https://t.co/lDpVfRtwiw,32,10,"{'hashtags': [{'text': 'merger', 'indices': [66, 73]}, {'text': 'agreement', 'indices': [74, 84]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/lDpVfRtwiw', 'expanded_url': 'https://twitter.com/i/web/status/1217896385523191808', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [114, 137]}]}",en
1217517905652436992,2020-01-15 18:44:23,Yesterday our CBO &amp; CCO Sean Marett discussed the future of cell &amp; gene therapies at the #BiotechShowcase highlight‚Ä¶ https://t.co/00DIe71k2H,20,6,"{'hashtags': [{'text': 'BiotechShowcase', 'indices': [97, 113]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/00DIe71k2H', 'expanded_url': 'https://twitter.com/i/web/status/1217517905652436992', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [125, 148]}]}",en
1216704138471530496,2020-01-13 12:50:46,We are excited to announce the #appointment of Ryan Richardson as Chief Strategy Officer and Managing Director. Rya‚Ä¶ https://t.co/FWrSxMU8pG,13,3,"{'hashtags': [{'text': 'appointment', 'indices': [31, 43]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/FWrSxMU8pG', 'expanded_url': 'https://twitter.com/i/web/status/1216704138471530496', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1215666095979474945,2020-01-10 16:05:57,"Meet Sean Marett, our CBO &amp; CCO at the #BiotechShowcase on January 14, 2020, in San Francisco, where he will discus‚Ä¶ https://t.co/cFQrMuHVTf",13,3,"{'hashtags': [{'text': 'BiotechShowcase', 'indices': [43, 59]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/cFQrMuHVTf', 'expanded_url': 'https://twitter.com/i/web/status/1215666095979474945', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",en
1214576061851328512,2020-01-07 15:54:33,Interested in European biotech companies? We are happy to be named one of the 20 European #biotech companies to fol‚Ä¶ https://t.co/uZkC89mgmI,21,5,"{'hashtags': [{'text': 'biotech', 'indices': [90, 98]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/uZkC89mgmI', 'expanded_url': 'https://twitter.com/i/web/status/1214576061851328512', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1212845721164095490,2020-01-02 21:18:48,Preclinical PoC data on our first solid #tumor #CART program BNT211 were published in the current issue of‚Ä¶ https://t.co/IVo69YJXXG,32,13,"{'hashtags': [{'text': 'tumor', 'indices': [40, 46]}, {'text': 'CART', 'indices': [47, 52]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/IVo69YJXXG', 'expanded_url': 'https://twitter.com/i/web/status/1212845721164095490', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [108, 131]}]}",en
1207295588896776192,2019-12-18 13:44:33,"We announced a ‚Ç¨50M financing from @EIB to advance R&amp;D, market access and manufacturing development of our most adv‚Ä¶ https://t.co/6p4tGZbqUi",21,4,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'EIB', 'name': 'European Investment Bank', 'id': 74720323, 'id_str': '74720323', 'indices': [35, 39]}], 'urls': [{'url': 'https://t.co/6p4tGZbqUi', 'expanded_url': 'https://twitter.com/i/web/status/1207295588896776192', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",en
1202564331650592768,2019-12-05 12:24:13,We are on top in @GENbio‚Äôs ranking of the 10 best immuno-oncology start-ups of 2019. Thanks @AlexWestchester for in‚Ä¶ https://t.co/F0oMRwPV5F,22,6,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'GENbio', 'name': 'Genetic Engineering & Biotechnology News', 'id': 31484145, 'id_str': '31484145', 'indices': [17, 24]}, {'screen_name': 'AlexWestchester', 'name': 'Alex Philippidis', 'id': 70020543, 'id_str': '70020543', 'indices': [92, 108]}], 'urls': [{'url': 'https://t.co/F0oMRwPV5F', 'expanded_url': 'https://twitter.com/i/web/status/1202564331650592768', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1197180054452744194,2019-11-20 15:49:02,Read more about our #CMO √ñzlem T√ºreci in @endpts special report on 20 extraordinary #women in #biopharma. √ñzlem is‚Ä¶ https://t.co/SEIZ5n5jue,23,6,"{'hashtags': [{'text': 'CMO', 'indices': [20, 24]}, {'text': 'women', 'indices': [84, 90]}, {'text': 'biopharma', 'indices': [94, 104]}], 'symbols': [], 'user_mentions': [{'screen_name': 'endpts', 'name': 'Endpoints News', 'id': 3460109487, 'id_str': '3460109487', 'indices': [41, 48]}], 'urls': [{'url': 'https://t.co/SEIZ5n5jue', 'expanded_url': 'https://twitter.com/i/web/status/1197180054452744194', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",da
1197149249839996930,2019-11-20 13:46:37,"Proud to be named company of the year at this year‚Äôs @LSXLeaders #lifestarawards, big thanks to the BioNTech family! https://t.co/mIrF1Yq472",19,4,"{'hashtags': [{'text': 'lifestarawards', 'indices': [65, 80]}], 'symbols': [], 'user_mentions': [{'screen_name': 'LSXLeaders', 'name': 'LSX Leaders', 'id': 2435194891, 'id_str': '2435194891', 'indices': [53, 64]}], 'urls': [{'url': 'https://t.co/mIrF1Yq472', 'expanded_url': 'https://twitter.com/LSXLeaders/status/1196915814903025669', 'display_url': 'twitter.com/LSXLeaders/sta‚Ä¶', 'indices': [117, 140]}]}",en
1197140555509223425,2019-11-20 13:12:04,Congrats to our CEO Ugur on receiving the #lifestaraward in the category private CEO of the year from @LSXLeaders https://t.co/9RDxvv6E6t,19,5,"{'hashtags': [{'text': 'lifestaraward', 'indices': [42, 56]}], 'symbols': [], 'user_mentions': [{'screen_name': 'LSXLeaders', 'name': 'LSX Leaders', 'id': 2435194891, 'id_str': '2435194891', 'indices': [102, 113]}], 'urls': [{'url': 'https://t.co/9RDxvv6E6t', 'expanded_url': 'https://twitter.com/LSXLeaders/status/1196917622216044545', 'display_url': 'twitter.com/LSXLeaders/sta‚Ä¶', 'indices': [114, 137]}]}",en
1195026114797805569,2019-11-14 17:10:02,"Today we announced our third quarter financial report, the first as a public company, detailing our progress for th‚Ä¶ https://t.co/rro6YUEXFd",17,6,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/rro6YUEXFd', 'expanded_url': 'https://twitter.com/i/web/status/1195026114797805569', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1194562480334344193,2019-11-13 10:27:43,"RT @Cormac_Sheridan: ""We're a Germany company. We think long-term."" Sean Marett @BioNTech_Group #BIOEurope",0,3,"{'hashtags': [{'text': 'BIOEurope', 'indices': [96, 106]}], 'symbols': [], 'user_mentions': [{'screen_name': 'Cormac_Sheridan', 'name': 'Cormac Sheridan', 'id': 308526080, 'id_str': '308526080', 'indices': [3, 19]}, {'screen_name': 'BioNTech_Group', 'name': 'BioNTech SE', 'id': 1060984350995550208, 'id_str': '1060984350995550208', 'indices': [80, 95]}], 'urls': []}",en
1194562461086765057,2019-11-13 10:27:39,"RT @Labiotech_eu: ‚ÄúAnyone who tells you that building a biotech company in Europe is easy is mistaken.‚Äù ‚Äî Sean Marett, COO of @BioNTech_Gro‚Ä¶",0,5,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'Labiotech_eu', 'name': 'Labiotech.eu', 'id': 2752355256, 'id_str': '2752355256', 'indices': [3, 16]}], 'urls': []}",en
1184044243616194560,2019-10-15 09:52:00,We are excited to announce the launch of our new website. We believe that our approach to treating cancer is unique‚Ä¶ https://t.co/Pa89VEzrtJ,13,3,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/Pa89VEzrtJ', 'expanded_url': 'https://twitter.com/i/web/status/1184044243616194560', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1182636473524326402,2019-10-11 12:38:02,We are proud to announce that BioNTech is now officially @Nasdaq. This is an important step on our journey to indiv‚Ä¶ https://t.co/jI7xyPkVEh,34,10,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'Nasdaq', 'name': 'Nasdaq', 'id': 18639734, 'id_str': '18639734', 'indices': [57, 64]}], 'urls': [{'url': 'https://t.co/jI7xyPkVEh', 'expanded_url': 'https://twitter.com/i/web/status/1182636473524326402', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1182296817238761472,2019-10-10 14:08:21,"It‚Äôs official! First day of trading begins for $BNTX on Thursday, October 10th at 9:30am ET (3:30pm CET)‚Ä¶ https://t.co/KRBetOfVRr",35,6,"{'hashtags': [], 'symbols': [{'text': 'BNTX', 'indices': [47, 52]}], 'user_mentions': [], 'urls': [{'url': 'https://t.co/KRBetOfVRr', 'expanded_url': 'https://twitter.com/i/web/status/1182296817238761472', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [106, 129]}]}",en
1148521810281078784,2019-07-09 09:18:32,"We are excited to announce the closing of a $325M #SeriesB round, one of the largest private #financing events for‚Ä¶ https://t.co/frj9Yr7963",70,27,"{'hashtags': [{'text': 'SeriesB', 'indices': [50, 58]}, {'text': 'financing', 'indices': [93, 103]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/frj9Yr7963', 'expanded_url': 'https://twitter.com/i/web/status/1148521810281078784', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1144201659528155136,2019-06-27 11:11:48,"RT @Labiotech_eu: Fireside chat with VP Business Alliances Holger Kissel of @BioNTech_Group - ""How to close a high-value drug development d‚Ä¶",0,2,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'Labiotech_eu', 'name': 'Labiotech.eu', 'id': 2752355256, 'id_str': '2752355256', 'indices': [3, 16]}, {'screen_name': 'BioNTech_Group', 'name': 'BioNTech SE', 'id': 1060984350995550208, 'id_str': '1060984350995550208', 'indices': [76, 91]}], 'urls': []}",en
1143148027168862209,2019-06-24 13:25:02,"BioNTech CBO/CCO, Sean Marett, is featured on our collaborator's @Roche website discussing advances in the #cancer-‚Ä¶ https://t.co/R9b7F0lxi1",15,3,"{'hashtags': [{'text': 'cancer', 'indices': [107, 114]}], 'symbols': [], 'user_mentions': [{'screen_name': 'Roche', 'name': 'Roche', 'id': 20815041, 'id_str': '20815041', 'indices': [65, 71]}], 'urls': [{'url': 'https://t.co/R9b7F0lxi1', 'expanded_url': 'https://twitter.com/i/web/status/1143148027168862209', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1140560661346496512,2019-06-17 10:03:46,We are delighted to announce the initiation of the #FirstinHuman Phase I/IIa study with #bispecific #antibody DuoBo‚Ä¶ https://t.co/wvgtFcGHjy,27,8,"{'hashtags': [{'text': 'FirstinHuman', 'indices': [51, 64]}, {'text': 'bispecific', 'indices': [88, 99]}, {'text': 'antibody', 'indices': [100, 109]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/wvgtFcGHjy', 'expanded_url': 'https://twitter.com/i/web/status/1140560661346496512', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1126158440244625408,2019-05-08 16:14:29,Today we announced the acquisition of MabVax Therapeutics‚Äô #antibody assets to expand our portfolio. See here for t‚Ä¶ https://t.co/esMJR3MVpt,17,7,"{'hashtags': [{'text': 'antibody', 'indices': [59, 68]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/esMJR3MVpt', 'expanded_url': 'https://twitter.com/i/web/status/1126158440244625408', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1101093704704638976,2019-02-28 12:16:11,Thank you at @techreview @BillGates for including us in the 10 breakthrough technologies of 2019! We are committed‚Ä¶ https://t.co/sLOLrzwYui,18,9,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'techreview', 'name': 'MIT Technology Review', 'id': 15808647, 'id_str': '15808647', 'indices': [13, 24]}, {'screen_name': 'BillGates', 'name': 'Bill Gates', 'id': 50393960, 'id_str': '50393960', 'indices': [25, 35]}], 'urls': [{'url': 'https://t.co/sLOLrzwYui', 'expanded_url': 'https://twitter.com/i/web/status/1101093704704638976', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1101048907226845184,2019-02-28 09:18:10,"We are delighted to announce that our CEO, Ugur Sahin was awarded the German Cancer Award 2019 by @DKG_Berlin, one‚Ä¶ https://t.co/g4AzK8KvZ8",34,8,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'DKG_Berlin', 'name': 'Krebsgesellschaft', 'id': 2793961019, 'id_str': '2793961019', 'indices': [98, 109]}], 'urls': [{'url': 'https://t.co/g4AzK8KvZ8', 'expanded_url': 'https://twitter.com/i/web/status/1101048907226845184', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1088052901505912833,2019-01-23 12:36:41,We have entered into an agreement to acquire MAB Discovery‚Äôs antibody generation unit. This follows a successful co‚Ä¶ https://t.co/tnL3o29yG0,17,6,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/tnL3o29yG0', 'expanded_url': 'https://twitter.com/i/web/status/1088052901505912833', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1081172322889928705,2019-01-04 12:55:43,We also extend a warm welcome to Ryan Richardson who will join our team as Senior VP Corporate Development &amp; Strate‚Ä¶ https://t.co/zIEghOHfNY,3,2,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/zIEghOHfNY', 'expanded_url': 'https://twitter.com/i/web/status/1081172322889928705', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",en
1081171005794648064,2019-01-04 12:50:29,Today we announced we are undergoing a corporate transition from AG to SE. The transition will enable greater flexi‚Ä¶ https://t.co/KQWJ19sPKu,3,4,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/KQWJ19sPKu', 'expanded_url': 'https://twitter.com/i/web/status/1081171005794648064', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1081169778461605888,2019-01-04 12:45:37,Today we announced that we have extended our research collaboration w/ @sanofi &amp; that Sanofi is investing $91.5m (‚Ç¨‚Ä¶ https://t.co/dUu1669LPY,20,5,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'sanofi', 'name': 'Sanofi', 'id': 35846368, 'id_str': '35846368', 'indices': [71, 78]}], 'urls': [{'url': 'https://t.co/dUu1669LPY', 'expanded_url': 'https://twitter.com/i/web/status/1081169778461605888', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",en
1076148642153676800,2018-12-21 16:13:24,Wishing everyone a wonderful holiday season and a great start in the new year! https://t.co/OgNRbg0JYp,9,3,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [], 'media': [{'id': 1076148556501839873, 'id_str': '1076148556501839873', 'indices': [79, 102], 'media_url': 'http://pbs.twimg.com/media/Du8_aRPXcAEg6am.jpg', 'media_url_https': 'https://pbs.twimg.com/media/Du8_aRPXcAEg6am.jpg', 'url': 'https://t.co/OgNRbg0JYp', 'display_url': 'pic.twitter.com/OgNRbg0JYp', 'expanded_url': 'https://twitter.com/BioNTech_Group/status/1076148642153676800/photo/1', 'type': 'photo', 'sizes': {'thumb': {'w': 150, 'h': 150, 'resize': 'crop'}, 'small': {'w': 680, 'h': 345, 'resize': 'fit'}, 'large': {'w': 1343, 'h': 682, 'resize': 'fit'}, 'medium': {'w': 1200, 'h': 609, 'resize': 'fit'}}}]}",en
1075457627289739265,2018-12-19 18:27:34,.@nature has published trial data demonstrating proof-of-concept of the @GAPVAC approach against glioblastoma. The‚Ä¶ https://t.co/9HkxMtIPBb,7,4,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'nature', 'name': 'Nature', 'id': 487833518, 'id_str': '487833518', 'indices': [1, 8]}, {'screen_name': 'GAPVAC', 'name': 'GAPVAC', 'id': 1229784878, 'id_str': '1229784878', 'indices': [72, 79]}], 'urls': [{'url': 'https://t.co/9HkxMtIPBb', 'expanded_url': 'https://twitter.com/i/web/status/1075457627289739265', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1075456386568515584,2018-12-19 18:22:38,.@GAPVAC published the first-in-human trial of a novel actively personalized therapeutic vaccine for #braincancer i‚Ä¶ https://t.co/xVw74PmEYx,13,5,"{'hashtags': [{'text': 'braincancer', 'indices': [101, 113]}], 'symbols': [], 'user_mentions': [{'screen_name': 'GAPVAC', 'name': 'GAPVAC', 'id': 1229784878, 'id_str': '1229784878', 'indices': [1, 8]}], 'urls': [{'url': 'https://t.co/xVw74PmEYx', 'expanded_url': 'https://twitter.com/i/web/status/1075456386568515584', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1071066319481700354,2018-12-07 15:38:04,...&amp; 2. ‚ÄúMammaTyper¬Æ - An in vitro quantitative local gene expression test as predictor of OncoType DX¬Æ - and EndoP‚Ä¶ https://t.co/dKXd3NL94f,4,3,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/dKXd3NL94f', 'expanded_url': 'https://twitter.com/i/web/status/1071066319481700354', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [121, 144]}]}",en
1071066318068178944,2018-12-07 15:38:04,"Join us today @SABCSSanAntonio for our MammaTyper¬Æ poster presentations:
1. ‚ÄúComparison of RT-qPCR with consensus i‚Ä¶ https://t.co/uCAI4NYfYZ",5,2,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'SABCSSanAntonio', 'name': 'SABCS', 'id': 2778609876, 'id_str': '2778609876', 'indices': [14, 30]}], 'urls': [{'url': 'https://t.co/uCAI4NYfYZ', 'expanded_url': 'https://twitter.com/i/web/status/1071066318068178944', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1071036248070983680,2018-12-07 13:38:35,"Get an update on BioNTech from our CBO/CCO, Sean Marett who had the opportunity to be interviewed by @ScripMikeWard‚Ä¶ https://t.co/3N45pZfuCN",6,3,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/3N45pZfuCN', 'expanded_url': 'https://twitter.com/i/web/status/1071036248070983680', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1070668109651042304,2018-12-06 13:15:44,We are pleased to have been included in @Labiotech_eu‚Äôs overview on ‚ÄòHow to Turn Your Biotech Startup into a Succes‚Ä¶ https://t.co/8vmw1CSPsF,8,3,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'Labiotech_eu', 'name': 'Labiotech.eu', 'id': 2752355256, 'id_str': '2752355256', 'indices': [40, 53]}], 'urls': [{'url': 'https://t.co/8vmw1CSPsF', 'expanded_url': 'https://twitter.com/i/web/status/1070668109651042304', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1070614762206191616,2018-12-06 09:43:45,"Join us @SABCSSanAntonio for our MammaTyper¬Æ poster presentations, ‚ÄúStandardized prediction of OncoType DX¬Æ risk cl‚Ä¶ https://t.co/antZvOqUDW",4,1,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'SABCSSanAntonio', 'name': 'SABCS', 'id': 2778609876, 'id_str': '2778609876', 'indices': [8, 24]}], 'urls': [{'url': 'https://t.co/antZvOqUDW', 'expanded_url': 'https://twitter.com/i/web/status/1070614762206191616', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1070234576268730368,2018-12-05 08:33:01,"Sean Marett, our CBO/CCO has been invited to be a panelist on the RNA panel titled, ‚ÄòThe year of RNA and the start‚Ä¶ https://t.co/ccafRhcN9Y",8,3,"{'hashtags': [], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/ccafRhcN9Y', 'expanded_url': 'https://twitter.com/i/web/status/1070234576268730368', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [116, 139]}]}",en
1069969927178731520,2018-12-04 15:01:24,"Join us @SABCSSanAntonio for our poster presentation, ""Highly innovative personalized RNA-immunotherapy for patient‚Ä¶ https://t.co/vNIU9gYyuQ",4,1,"{'hashtags': [], 'symbols': [], 'user_mentions': [{'screen_name': 'SABCSSanAntonio', 'name': 'SABCS', 'id': 2778609876, 'id_str': '2778609876', 'indices': [8, 24]}], 'urls': [{'url': 'https://t.co/vNIU9gYyuQ', 'expanded_url': 'https://twitter.com/i/web/status/1069969927178731520', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1069545434803245057,2018-12-03 10:54:37,"Our CBO/CCO, Sean Marett had the opportunity to be interviewed by @ScripMikeWard during #BIOEurope2018. Sean gave m‚Ä¶ https://t.co/kEFUqg5b9x",8,1,"{'hashtags': [{'text': 'BIOEurope2018', 'indices': [88, 102]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/kEFUqg5b9x', 'expanded_url': 'https://twitter.com/i/web/status/1069545434803245057', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1068088618097491968,2018-11-29 10:25:45,RT @PharmaScrip: The Private Financing Deal of the Year goes to BioNTech's $270m Series A Financing. Congratulations! #ScripAwards2018,0,6,"{'hashtags': [{'text': 'ScripAwards2018', 'indices': [118, 134]}], 'symbols': [], 'user_mentions': [{'screen_name': 'PharmaScrip', 'name': 'Scrip', 'id': 21079030, 'id_str': '21079030', 'indices': [3, 15]}], 'urls': []}",en
1068077849146519552,2018-11-29 09:42:57,We are honored to have been awarded the Financing Deal of the Year 2018 at the #ScripAwards in London last night. T‚Ä¶ https://t.co/aITb2GQ5S7,10,4,"{'hashtags': [{'text': 'ScripAwards', 'indices': [79, 91]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/aITb2GQ5S7', 'expanded_url': 'https://twitter.com/i/web/status/1068077849146519552', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
1068055767335481344,2018-11-29 08:15:13,"BioNTech is excited to join in the conversation around #mRNA, #individualized immunotherapies and #biotech on Twitt‚Ä¶ https://t.co/EVji06zK35",14,6,"{'hashtags': [{'text': 'mRNA', 'indices': [55, 60]}, {'text': 'individualized', 'indices': [62, 77]}, {'text': 'biotech', 'indices': [98, 106]}], 'symbols': [], 'user_mentions': [], 'urls': [{'url': 'https://t.co/EVji06zK35', 'expanded_url': 'https://twitter.com/i/web/status/1068055767335481344', 'display_url': 'twitter.com/i/web/status/1‚Ä¶', 'indices': [117, 140]}]}",en
